Clincosm LogoSign in Get a demo

healthy participant

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)

Completed
  • Healthy Participant
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 11, 2023

Healthy Participant Trial (DNL919, Placebo)

Recruiting
  • Healthy Participant
  • Leiden, South Holland, Netherlands
    Centre for Human Drug Research (CHDR)
Sep 14, 2022

Healthy Participant Trial in Paris (Club event)

Completed
  • Healthy Participant
  • Club event
  • Paris, France
    ANRS
Apr 1, 2022

Healthy Participant Trial in New Haven (PF-07321332/ritonavir, Carbamazepine, PF 07321332/ritonavir)

Completed
  • Healthy Participant
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Oct 18, 2021

Healthy Participant Trial in Brussels (PF-07321332/ritonavir, Itraconazole)

Completed
  • Healthy Participant
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Oct 11, 2021

Healthy Participant Trial in Ankara (Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group), Selective-etch mode with

Active, not recruiting
  • Healthy Participant
  • Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group)
  • +4 more
  • Ankara, Turkey
    Hacettepe University Faculty of Dentistry
Mar 25, 2021

Healthy Participant Trial in Ankara (G-Premio Bond in etch&rinse mode, G-Premio Bond in selective-etch mode, G-Premio Bond in

Active, not recruiting
  • Healthy Participant
  • G-Premio Bond in etch&rinse mode
  • +2 more
  • Ankara, Turkey
    Hacettepe University Faculty of Dentistry
Mar 19, 2021